Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2020.00219
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

CDK4 Expression in Chordoma: A Potential Therapeutic Target Running Title: CDK4 Expression in Chordoma

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2017English

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Novel Targeted Therapies in Adrenocortical Carcinoma

Current Opinion in Endocrinology, Diabetes and Obesity
Internal MedicineNutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2016English

Network Analysis Reveals Potential Markers for Pediatric Adrenocortical Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Flies Selected for Longevity Retain a Young Gene Expression Profile

AGE
2010English

CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Diagnostic Value of Riz1 Gene Expression as a Potential Marker for Patients With Hepatocellular Carcinoma.

International Journal of Advanced Research
2016English

Gene Expression Signatures as a Therapeutic Target for Severe H7N9 Influenza – What Do We Know So Far?

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2015English

CDK4 as a Phytochemical Based Anticancer Drug Target

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy